# A Plasma eMTBR-Tau Immunoassay for Detection of Advanced Insoluble Tau Pathology

> **Open Intelligence Dossier** · First detected: 2026-11-17 18:20 UTC · Category: Health

## Executive Summary
A new plasma immunoassay measuring eMTBR-tau detects advanced insoluble tau pathology in Alzheimer's disease with accuracy comparable to mass spectrometry across four cohorts.

## Intelligence Brief
Researchers have developed a plasma immunoassay for endogenously cleaved microtubule-binding region tau (eMTBR-tau) that identifies advanced tau pathology in Alzheimer&#039;s disease, according to a study published in JAMA. The assay was validated across four independent cohorts and produced results comparable to those obtained with mass spectrometry, the current reference standard for measuring tau species in biofluids. The test targets a specific tau fragment containing residue 243 that originates from the microtubule-binding region of the protein, which becomes exposed when tau aggregates into insoluble filaments characteristic of advanced Alzheimer&#039;s pathology.


The same JAMA publication reports that fluid eMTBR-tau containing residue 243 may also serve as a potential diagnostic biomarker for late-stage chronic traumatic encephalopathy (CTE) and symptomatic frontotemporal lobar degeneration, based on a case-control study included in the research. This suggests the biomarker could have utility across multiple neurodegenerative conditions characterized by tau aggregation.


Separately, a cohort study published in JAMA Neurology found that blood levels of phosphorylated tau 217 (p-tau217) in cognitively unimpaired individuals were linked with 5- and 10-year risks of developing mild cognitive impairment and dementia. This reinforces the growing evidence that blood-based tau biomarkers can track disease progression years before symptom onset. Meanwhile, a systematic review and meta-analysis in Alzheimer&#039;s Research &amp; Therapy reported that people with type 2 diabetes had a 53% higher risk of Alzheimer&#039;s disease, highlighting a significant metabolic risk factor for the condition.


Other recent neuroscience findings include reduced cerebrospinal fluid waves during sleep in older adults, which may impair brain debris clearance, and EEG data showing sleep-like slow waves during wakefulness in Parkinson&#039;s disease patients correlating with hallucinations and cognitive impairment. A study of over 2,000 MRIs revealed that highly connected neural hubs are particularly vulnerable to atrophy in multiple sclerosis. In autism research, functional MRI data showed greater variability in encoding patterns across nearly all brain networks when autistic adults watched videos compared to neurotypical controls. The BRAIN Initiative has also produced a shared basal ganglia reference atlas mapping millions of cells across non-human primate, marmoset, and mouse brains. In a separate development, Cell Reports retracted a 2025 study on Parkinson&#039;s disease models from Denali Therapeutics scientists due to data manipulation.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Physicians Weekly | Why Early Detection Matters, and Why It Is Not Screening | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxPVDRydUJYU1o4N0pneTN1Uy1BTW1WNVFXS3p5YUo2OVNtLXQyMDdUR0kyaVp0RWlMcGFNNFdJQ0l4WFdwQ0NGMVlua1NrS3o5S3QyQkY5WjhuUHhpbWNwRklpaTBxNWN2Rnc3VFg0MDlKaWp4dmFhN0h1ZXdSTjdoQ3A5dDQ0SURhUEk4RFdzOVpiWjVGQUJ5Uw?oc=5) |
| The Hill | Watch live: The Promise of Early Intervention — The ASAP Act and A New Look at Life with Alzheimer’s | [Source Link](https://news.google.com/rss/articles/CBMi2AFBVV95cUxOeWQxQk04c2xUcjJ1bVNjLVpSOFprMWNJUjMxR0tleU5tVUZTbnBJNTJXbTJ5SWJfaE83TVpHeG9xVi1nWDNMdC1uV042Z0R5ME5mYmo5LWxiU1VqSWxBczVxVERUUlNBMG80RGR2MEIxZGlQRmthWWFrRUpVbjl4amJOS0gySVRyYjRTMUNXMzdKZmpJcUxjMUpIWlcyaHVSejJIWGUxa0dnMVpFejQ5YU80bkc5SFpOMFBJQ0VXMGtwdzJjXzQ2cVF6MzUtbHR3SEtuVTMzVkjSAd4BQVVfeXFMUFRXTWhEZE1NSndaTGNOQU9TSC1jV1EzNDM5TGxGcjg2dGRCQmI3VDdocHQ3cUw0R3QtcWpraFV3alFfa1NqTnVhX3RreTI5ajJnd2gtMkQ5UFZFZnpkZmVleXd5a01RTnFEVFkzbEZldXpTZXpreWZGRDM) |
| MedPage Today | Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted | [Source Link](https://news.google.com/rss/articles/CBMib0FVX3lxTE54QVVjUVJwNHVmelVfT2xsaEx4cUs4VzktMlJHYTRmZVdSLURTa3lxcF9idEJXcjZXb01yeWlDT19JMW91LVVqRFNQakVGRDVPYlh3SHNJWWozNGRkb1Y2LXRTeUpiNU8tZ3lXcm1Oaw?oc=5) |
| Inside Precision Medicine | New Blood Test Could Make Measuring Advanced Alzheimer’s Disease More Accessible | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxONWdOeTBEYUZ5MXgzYUI1SGVMN3FtbktwZTBTYkFURllteGVtZ3pRT21uZHZhVVZtOUJ1N2JzQjE0OWRwbi1kcllHekJxQ3RzM2RaZjYyUlpoR1NLMmIyVDd1Z21CNHNlQTVMQlU3b01sTmVFdldaN1N6YUpFT1ItUjRCc2NRZ1J4b1ZUaktvR2hMcUpQb1VDMGIwazBiY2c4aHJvbjlXdHByZXRpYUtCTjdibGtjQ05sNHk0dUZSRll5VW9TallpWXhWd21yNEhldEhpVXdMSQ?oc=5) |
| CT Insider | Opinion: Alzheimer's won't wait. Neither should we | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxQcWpDaHFhOUpYNllDTWxvdnVtcnFYbWY2YlFZdW9ubGowbUdWd3I4SUg5R1hrXzQ3N1hmMk9tS2J0NmQ3eGhSOF9mMEdYU21CeDNYandhS21JUTRzbXNYb1RoeDQxSGd3Q1g3d0o0U05aUG9sWGY0YmVQVjJlYTFNVEZaNVNFMU5kTVZBTC1fWWJrd0E?oc=5) |
| News-Medical | Blood biomarker helps estimate a person's future risk of cognitive impairment | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxNUjVQajJGazFRZWhtZ1l0UGFqdzhJWG5qclA3VDJJejVrbjVfcEZGZ0lIbWswZHk3YkFvTHJsdTJBTTB1eERiSjZ4cXVnUGR0ZGRHaHU3RnpxWjZic1cwV1JPWmJZX0xzZE5sOVNoZ205Rjl3VVNqaDN2RDZvQlNLWGw1UjRkeFQ5am5xeVpaNGFwU21JcnF6ZWtRUkJiTVVJOU9SYXpfMVRmd0phRDBOd1R3dThiSWJNWU13WWs1U0xaZw?oc=5) |
| Forbes | Tested Positive For Alzheimer's? You May Never Get Sick | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxPcEdBLUlONFZaNldSU3VwMHZQXzloMGVSNG1Pa0x0WXRDU3hlVDlkR25IU25xbzNmMlBpUGV4S0lSeU5JY3RWb1doLXc2U1N5QWpBU1U3bG4tSGpCdFkwNmJSeEk4cjRmdDRmYzB5UlZRNTNnMDhvaEJKeE5fZ0ljS1dTMmVOU1JYZjJPeExfNFpmbmw1RFFVeWhNbERXWG5zQVhDRzNPU0o?oc=5) |
| JAMA | A Plasma eMTBR-Tau Immunoassay for Detection of Advanced Insoluble Tau Pathology | [Source Link](https://news.google.com/rss/articles/CBMiaEFVX3lxTE1xUDd3Q0prTTFsVENSdWw0YnNYVFNzd1lvaTNtekQySFc5aXpZZ1ZTVnV3MkthVW91WTRJWVJGUmhfZEN3Z0Y3U3o3SmRLU3MwejQ5TFFybGk2UmJpd0ptbV9iVTNYUmNz?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-11-17/a-plasma-emtbr-tau-immunoassay-for-detection-of-advanced-insoluble-tau-pathology*
